v3.24.3
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Sep. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 3,244,806 $ 25,845,915
Restricted cash 0 10,000,000
Accounts receivable, less allowance for credit losses of $0.2 million and $0.2 million as of September 30, 2024 and December 31, 2023, respectively 682,673 2,326,774
Other receivables 3,002,143 2,143,435
Inventory, net 43,186,462 45,408,192
Prepaid expenses and other current assets 7,357,838 8,101,162
Total current assets 57,473,922 93,825,478
Property, plant and equipment, net 34,825,810 37,876,955
Operating lease right-of-use assets, net 3,465,637 4,174,800
Finance lease right-of-use assets, net 5,470,933 5,621,181
Other assets 176,310 176,310
Total Assets 101,412,612 141,674,724
Current liabilities:    
Accounts payable 10,572,525 12,456,272
Accrued and other current liabilities 8,384,321 4,862,740
Deferred revenue 6,350,581 4,714,331
Warranty liability 776,423 1,902,647
Operating lease liabilities, current 1,001,120 1,012,428
Finance lease liabilities, current 2,100,635 2,548,184
Warrant liability 7,229,919 5,605,325
Current portion of convertible notes 13,182,467 20,180,100
Total current liabilities 49,597,991 53,282,027
Operating lease liabilities, long-term 4,556,738 5,280,526
Total Liabilities 54,154,729 58,562,553
Commitments and contingencies
Stockholders’ Equity:    
Common stock, par value $0.001 per share, 450,000,000 shares authorized, 31,862,091 shares issued and outstanding as of September 30, 2024 and 14,299,042 shares issued and outstanding as of December 31, 2023 (presented on a reverse stock split-adjusted basis) 31,862 14,299
Additional paid-in capital 879,405,617 834,666,123
Accumulated deficit (832,179,596) (751,568,251)
Total stockholders’ equity 47,257,883 83,112,171
Total Liabilities and Stockholders’ Equity $ 101,412,612 $ 141,674,724

Source